This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc
and you are
between 18 and 65
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To evaluate the safety and tolerability of escalating, single subcutaneous doses of MEDI7734 in adult subjects with type I interferon-mediated autoimmune diseases.

Provided treatments

  • Biological: MEDI7734
  • Biological: Placebo
Tris trial is registered with FDA with number: NCT02780674. The sponsor of the trial is MedImmune LLC and it is looking for 36 volunteers for the current phase.
Official trial title:
A Phase 1, Randomized, Blinded, Single-Dose, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases